Image

The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer

Researching DNA Nanomachines for Detecting microRNA in Pancreatic Cancer Diagnosis

Recruiting
20 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer. It explores the use of DNA nanomachines for detecting microRNA in the blood.

The study evaluates the role of these DNA nanomachines and their potential applications in diagnosing pancreatic cancer by developing a fluorescence sensing platform.

  • Who can participate: Adults 20 years and older with pancreatic ductal adenocarcinoma proven by pathology can participate. Participants should not have received any anti-cancer therapies and must not have other active malignancies.
  • Study details: Participants will have their blood tested using an investigational method involving DNA nanomachines to detect microRNA. This method employs a fluorescence sensing platform for dual signal amplification. An inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine is not involved.
Print
Study details
    Pancreas Adenocarcinoma
    MicroRNA

NCT06497777

National Taiwan University Hospital

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.